Fri, Feb 16, 2024
Why the rise in Glenmark Pharma? What is special about Glenmark Pharma's Concol?
More >
Thu, Feb 15, 2024
Glenmark Pharma stock recovers after posting Rs 330.8 crore net loss in Q3. Sales dip due to one-time India impact, forex loss, inflation. Revenue excluding one-time impact up 9% YoY. Gross margins down 750 bps YoY to 58.8%.
Fri, Sep 29, 2023
Positive S&P on Glenmark Pharma. S&P changed the company's outlook from stable to positive. Outlook improved due to sale of 75% stake in Glenmark Life
Thu, Sep 21, 2023
Glenmark Pharma's big deal, GlenmarkPharma has sold 75% stake in its subsidiary GLS.
Wed, Sep 20, 2023
Good growth in US generics market – which pharma stocks will benefit? Why did US business pick up pace? How is the growth in the US generic market - know in this video.
Thu, Oct 06, 2022
The Mumbai-based drug firm has launched the medication under the brand name LOBG and is priced at around Rs 10 per tablet.
Mon, Mar 20, 2017
Glenmark’s current portfolio consists of 112 products authorized for distribution in the US marketplace.
Thu, Feb 02, 2017
The company's total income increased to Rs 2549.5 crore in Q3FY17 as compared to Rs 1780.4 crore in Q3FY16.
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
